UAE antibiotics market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of advancing pharmaceutical industry in the country. Growing instances of infectious diseases and evolving microorganisms that affect human health is further driving the growth of the UAE antibiotic market in the upcoming five years.

Antibiotics are the medicinal components that have ability to either kill the bacteria that are causing the diseases or disorders or can hinder their life cycles. Thus, they are also called as antibacterial. Antibiotics are incapable to counter act on viral infections like cold, flu, etc. since viruses unlike bacteria do not have cell wall that can be broken to kill the infection. Also, the viruses utilize human cells to complete their replication process thus killing viruses leads to considerable harm to the human cells too. Thus, antibodies are utilized to overcome bacterial infections.

Expansion of Pharmaceutical Industry Promises Market Growth

The healthcare industry is expanding due to increasing investments and growing expenses by the population. The pharmaceutical industry is also expanding with its fair share of investments. A sustainable growth for the pharmaceutical industry in the UAE is based on long term plans like Dubai Industrial Strategy 2030 and the Abu Dhabi vision 2030. In the year 2021, USD1.4 billion were allocated for healthcare services by the UAE government.

Moreover, the government is inclined on decreasing the imports of pharmaceuticals & therapeutic products to minimize the cost of healthcare in the country. The government imports large quantities of pharmaceuticals to satisfy the growing demands of antibiotics and other pharmaceuticals. Dubai alone accounts for 18% of the pharmaceutical imports in the country that valued at USD4 billion in 2021. Increasing penetration of market players from the countries like India would support the market growth as well as Dubai has the potential to be MENA region’s pharmaceutical hub. This would increase the volume of the product available and value of the UAE antibiotics market.

COVID-19 Infection Boomed Market Growth

Recent pandemic situation created vast demands for antibiotics and antiviral pharmaceuticals as treatment from the COVID-19 infection. In UAE 77% of deaths are caused due to non-communicable diseases. Increasing instances of infectious and non-communicable diseases are aiding to the demands for antibiotics and thus driving the growth of the UAE antibiotics market in the upcoming five years. COVID-19 infections as of March 2022, has spread 886,301 in the country. Consistent increase in the patient count and demands for the medicines and drugs to counter the effects of viral infection aids the market growth in future five years.


Click here to download the sample

Market Segmentation

The UAE antibiotics market is segmented by drug class, spectrum, source, route of administration, distribution channel, competitional landscape, and regional distribution. Based on drug class, the market is further segmented into cephalosporin, penicillin, amoxicillin, azithromycin, clindamycin, tetracycline, and others. By spectrum, the market is differentiated between broad spectrum antibiotics and narrow spectrum antibiotics. Based on source, the market is fragmented into natural, semisynthetic, and synthetic. By route of administration, the market is distinguished between oral and intravenous. Based on distribution channel, the market is bifurcated into hospital pharmacy, retail pharmacy, and online pharmacy. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi, Dubai, Sharjah, rest of UAE.

Company Profile

Novartis UAE, Pfizer UAE, Glenmark Pharmaceuticals UAE, GlaxoSmithKline UAE, AstraZeneca UAE, among others is a partial list of major market players of the companies responsible for the growth of UAE antibiotics market.



Base Year


Historical Data

2017 – 2020

Estimated Year


Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Drug Class

·         Spectrum

·         Source

·         Route of Administration

·         Distribution Channel

Regional scope

Abu Dhabi, Dubai, Sharjah, Rest of UAE.

Key companies profiled

Novartis UAE, Pfizer UAE, Glenmark Pharmaceuticals UAE, GlaxoSmithKline UAE, AstraZeneca UAE

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, UAE antibiotics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • UAE Antibiotics Market, By Drug Class:
    • Cephalosporin
    • Penicillin
    • Amoxicillin
    • Azithromycin
    • Clindamycin
    • Tetracycline
    • Others
  • UAE Antibiotics Market, By Spectrum:
    • Broad Spectrum Antibiotics
    • Narrow Spectrum Antibiotics
  • UAE Antibiotics Market, By Source:
    • Natural
    • Semisynthetic
    • Synthetic
  • UAE Antibiotics Market, By Route of Administration:
    • Oral
    • Intravenous
  • UAE Antibiotics Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • UAE Antibiotics Market, By Region:

o   Abu Dhabi

o   Dubai

o   Sharjah

o   Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in UAE antibiotics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

UAE Antibiotics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on UAE Antibiotics Market

4.    Voice of Customer

5.    Executive Summary

6.    UAE Antibiotics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Class (Cephalosporin, Penicillin, Amoxicillin, Azithromycin, Clindamycin, Tetracycline, Others)

6.2.2.     By Spectrum (Broad Spectrum Antibiotics v/s Narrow Spectrum Antibiotics)

6.2.3.     By Source (Natural, Semisynthetic, Synthetic)

6.2.4.     By Route of Administration (Oral v/s Intravenous)

6.2.5.     By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

6.2.6.     By Company (2021)

6.2.7.     By Region

6.3.  Product Market Map

7.    UAE Broad Spectrum Antibiotics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Drug Class

7.2.2.     By Source

7.2.3.     By Route of Administration

7.2.4.     By Distribution Channel

8.    UAE Narrow Spectrum Antibiotics Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Drug Class

8.2.2.     By Source

8.2.3.     By Route of Administration

8.2.4.     By Distribution Channel

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  UAE Economic Profile

13.  Competitive Landscape

13.1.              Competition Outlook

13.2.              Company Profiles

13.2.1.  Novartis UAE

13.2.2.  Pfizer UAE

13.2.3.  Glenmark Pharmaceuticals UAE

13.2.4.  GlaxoSmithKline UAE

13.2.5.  AstraZeneca UAE

 14. Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]